Molecular Mechanism of Transformation from Adenocarcinoma to Small-Cell Lung Cancer after EGFR-TKI

被引:1
|
作者
Han, Jiefei [1 ]
Zhang, Qiuyi [2 ,3 ]
Wang, Binchao [2 ,3 ]
Zhou, Qing [2 ,3 ]
Yan, Lixu [2 ,3 ]
Zhang, Zhou [4 ]
Chen, Huajun [2 ,3 ]
Su, Jian [2 ,3 ]
Xie, Zhi [2 ,3 ]
Niu, Feiyu [2 ,3 ]
Wu, Yi Long [2 ,3 ]
Chuai, Shannon [4 ]
Yang, Jinji [2 ,3 ]
Dong, Zhong-Yi [2 ]
机构
[1] Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[2] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[3] Guangdong Acad Med Sci, Guangdong Key Lab Lung Canc Translat Med, Guangzhou, Guangdong, Peoples R China
[4] Burning Rock Dx Ltd, Guangzhou, Guangdong, Peoples R China
关键词
SCLC; transformation; EGFR-TKI; NSCLC;
D O I
10.1016/j.jtho.2016.11.1784
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.02b-116
引用
收藏
页码:S1263 / S1264
页数:2
相关论文
共 50 条
  • [21] Analysis of the EGFR mutations in non-small cell lung cancer patients after EGFR-TKI treatment.
    Yamaguchi, H.
    Ikeda, T.
    Tomonaga, N.
    Nakano, H.
    Kitazaki, T.
    Doi, S.
    Nakatomi, K.
    Iida, T.
    Nakamura, Y.
    Kohno, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] A case with small-cell transformation after treatment with EGFR tyrosine kinase inhibitor for lung adenocarcinoma
    Osoegawa, Atsushi
    Hashimoto, Takafumi
    Yohei, Takumi
    Miyuki, Abe
    Shuji, Suehiro
    Michiyo, Miyawaki
    Kenji, Sugio
    ANNALS OF ONCOLOGY, 2015, 26 : 138 - 139
  • [23] Squamous cell carcinoma transformation from adenocarcinoma as an acquired resistance after the EGFR TKI therapy in (EGFR-mutated) non-small cell lung cancer
    Shinohara, Shinji
    Ichiki, Yoshinobu
    Fukuichi, Yukiko
    Honda, Yohei
    Kanoyama, Masatoshi
    Taira, Akihiro
    Nabe, Yusuke
    Kuwata, Taiji
    Takenaka, Masaru
    Oka, Soichi
    Chikaishi, Yasuhiro
    Hirai, Ayako
    Imanishi, Naoko
    Kuroda, Koji
    Yoneda, Kazue
    Noguchi, Hirotsugu
    Tanaka, Fumihiro
    JOURNAL OF THORACIC DISEASE, 2018, 10 (07) : E526 - E531
  • [24] Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI
    Guo-Hao Xia
    Yun Zeng
    Ying Fang
    Shao-Rong Yu
    Li Wang
    Mei-Qi Shi
    Wei-Li Sun
    Xin-En Huang
    Jia Chen
    Ji- Feng Feng
    Cancer Biology & Medicine, 2014, (04) : 270 - 276
  • [25] Efficacy and safety of apatinib plus EGFR-TKI in advanced non-small cell lung cancer with EGFR-TKI resistance (date updated)
    Tian, R.
    Guo, W.
    Guo, Y.
    Zhang, X.
    Zhu, H.
    Shen, F.
    Zhang, X.
    Wang, R.
    Ren, X.
    Li, J.
    Song, X.
    ANNALS OF ONCOLOGY, 2020, 31 : S873 - S873
  • [26] Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI
    Guo-Hao Xia
    Yun Zeng
    Ying Fang
    Shao-Rong Yu
    Li Wang
    Mei-Qi Shi
    Wei-Li Sun
    Xin-En Huang
    Jia Chen
    Ji- Feng Feng
    Cancer Biology & Medicine, 2014, 11 (04) : 270 - 276
  • [27] EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
    Kyoko Otsuka
    Akito Hata
    Jumpei Takeshita
    Chiyuki Okuda
    Reiko Kaji
    Katsuhiro Masago
    Shiro Fujita
    Nobuyuki Katakami
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 835 - 841
  • [28] EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
    Otsuka, Kyoko
    Hata, Akito
    Takeshita, Jumpei
    Okuda, Chiyuki
    Kaji, Reiko
    Masago, Katsuhiro
    Fujita, Shiro
    Katakami, Nobuyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 835 - 841
  • [29] Progress in the knowledge on the transformation of lung adenocarcinoma to small-cell lung cancer
    Wang, Aiguang
    Han, Cuiping
    Zhao, Hui
    Zheng, Zhaomin
    Ye, Xin
    Shan, Rong
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (01) : 14 - 19
  • [30] The Role of Surgical Resection of Advanced Non-Small Cell Lung Cancer after a Response to EGFR-TKI
    Chen, Y.
    Su, P.
    Chang, C.
    Yen, Y.
    Lin, C.
    Su, W.
    Tseng, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S623 - S624